These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2297117)

  • 1. Plasma concentrations of laudanosine, but not of atracurium, are increased during the anhepatic phase of orthotopic liver transplantation in pigs.
    Pittet JF; Tassonyi E; Schopfer C; Morel DR; Mentha G; Fathi M; Le Coultre C; Steinig DA; Benakis A
    Anesthesiology; 1990 Jan; 72(1):145-52. PubMed ID: 2297117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma laudanosine levels in patients given atracurium during liver transplantation.
    Lawhead RG; Matsumi M; Peters KR; Landers DF; Becker GL; Earl RA
    Anesth Analg; 1993 Mar; 76(3):569-73. PubMed ID: 8452269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concentrations of atracurium and laudanosine in cerebrospinal fluid and plasma during intracranial surgery.
    Eddleston JM; Harper NJ; Pollard BJ; Edwards D; Gwinnutt CL
    Br J Anaesth; 1989 Nov; 63(5):525-30. PubMed ID: 2605068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of age on cis-atracurium besylate pharmacokinetics following a single 1 mg kg
    Aguilar A; Andaluz A; Moll X; Cristòfol C; García F
    Vet Anaesth Analg; 2019 Sep; 46(5):643-651. PubMed ID: 31155378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic modelling of a parent drug and its metabolite. Atracurium and laudanosine.
    Nigrovic V; Banoub M
    Clin Pharmacokinet; 1992 May; 22(5):396-408. PubMed ID: 1505145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concentrations of atracurium and laudanosine in cerebrospinal fluid and plasma in three intensive care patients.
    Gwinnutt CL; Eddleston JM; Edwards D; Pollard BJ
    Br J Anaesth; 1990 Dec; 65(6):829-32. PubMed ID: 2265055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose requirements and plasma concentrations of pipecuronium during bilateral renal exclusion and orthotopic liver transplantation in pigs.
    Pittet JF; Tassonyi E; Schopfer C; Morel DR; Leemann P; Mentha G; Le Coultre C; Steinig DA; Benakis A
    Br J Anaesth; 1990 Dec; 65(6):779-85. PubMed ID: 2176089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of laudanosine following infusion of atracurium in man and its effects on awakening.
    Beemer GH; Bjorksten AR; Dawson PJ; Crankshaw DP
    Br J Anaesth; 1989 Jul; 63(1):76-80. PubMed ID: 2765346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the pharmacodynamics and pharmacokinetics of an infusion of cis-atracurium (51W89) or atracurium in critically ill patients undergoing mechanical ventilation in an intensive therapy unit.
    Boyd AH; Eastwood NB; Parker CJ; Hunter JM
    Br J Anaesth; 1996 Mar; 76(3):382-8. PubMed ID: 8785138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the infusion pharmacokinetics and pharmacodynamics of cisatracurium, the 1R-cis 1'R-cis isomer of atracurium, with atracurium besylate in healthy patients.
    Smith CE; van Miert MM; Parker CJ; Hunter JM
    Anaesthesia; 1997 Sep; 52(9):833-41. PubMed ID: 9349062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atracurium infusions in patients with fulminant hepatic failure awaiting liver transplantation.
    Bion JF; Bowden MI; Chow B; Honisberger L; Weatherley BC
    Intensive Care Med; 1993; 19 Suppl 2():S94-8. PubMed ID: 8106686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and dynamics of atracurium infusions after paediatric orthotopic liver transplantation.
    Chow B; Bowden MI; Ho E; Weatherley BC; Bion JF
    Br J Anaesth; 2000 Dec; 85(6):850-5. PubMed ID: 11732518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition of infusions of atracurium and its metabolite, laudanosine, in patients in renal and respiratory failure in an ITU.
    Parker CJ; Jones JE; Hunter JM
    Br J Anaesth; 1988 Nov; 61(5):531-40. PubMed ID: 3207525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atracurium decay and the formation of laudanosine in humans.
    Nigrovic V; Fox JL
    Anesthesiology; 1991 Mar; 74(3):446-54. PubMed ID: 2001023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prolonged use of atracurium in a patient with tetanus.
    Peat SJ; Potter DR; Hunter JM
    Anaesthesia; 1988 Nov; 43(11):962-3. PubMed ID: 3213921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Atracurium in the elderly subject].
    d'Hollander A; Barvais L; Hennart D; Baurain M
    Ann Fr Anesth Reanim; 1985; 4(6):492-4. PubMed ID: 2936288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of atracurium and laudanosine in patients with hepatic cirrhosis.
    Parker CJ; Hunter JM
    Br J Anaesth; 1989 Feb; 62(2):177-83. PubMed ID: 2923767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clearance of atracurium and laudanosine in the urine and by continuous venovenous haemofiltration.
    Shearer ES; O'Sullivan EP; Hunter JM
    Br J Anaesth; 1991 Nov; 67(5):569-73. PubMed ID: 1751271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of atracurium and laudanosine in the elderly.
    Kent AP; Parker CJ; Hunter JM
    Br J Anaesth; 1989 Dec; 63(6):661-6. PubMed ID: 2611066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplacental distribution of atracurium, laudanosine and monoquaternary alcohol during elective caesarean section.
    Shearer ES; Fahy LT; O'Sullivan EP; Hunter JM
    Br J Anaesth; 1991 May; 66(5):551-6. PubMed ID: 2031814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.